Episode Details
Back to EpisodesEvolving CLL Therapy: The Power of Doublet and Triplet Regimens
Episode 513
Published 1 year, 2 months ago
Description
John N. Allan, MD and Andrew H. Lipsky, MD discuss the evolution of CLL therapy and the power of doublet and triplet regimens, exploring combinations including BTK inhibitors with BCL-2 inhibitors and anti-CD20 monoclonal antibodies.